行情

SPPI

SPPI

光谱制药
NASDAQ

实时行情|Nasdaq Last Sale

3.040
-0.020
-0.65%
盘后: 3.110 +0.07 +2.30% 19:59 02/21 EST
开盘
3.030
昨收
3.060
最高
3.150
最低
2.990
成交量
173.52万
成交额
--
52周最高
12.15
52周最低
2.480
市值
3.43亿
市盈率(TTM)
-2.2862
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测SPPI价格均价为9.75,最高价位13.00,最低价为4.000。

EPS

SPPI 新闻

更多
  • What Awaits Spectrum Pharmaceuticals (SPPI) in Q4 Earnings?
  • Zacks · 2天前
  • Spectrum Pharmaceuticals Announces Fourth Quarter and Full Year 2019 Financial Results Conference Call
  • Business Wire · 2天前
  • Spectrum Pharmaceuticals to Present Corporate Update at the Guggenheim Healthcare Talks Idea Forum Oncology Day on February 13th
  • Business Wire · 02/06 12:00
  • The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
  • Benzinga · 01/28 14:03

所属板块

生物技术和医学研究
+0.37%
制药与医学研究
+0.54%

热门股票

代码
价格
涨跌幅
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

SPPI 简况

Spectrum Pharmaceuticals, Inc. is a biopharmaceutical company. The Company operates through developing and commercializing oncology and hematology drug products segment. It focuses on developing ROLONTIS and POZIOTINIB. ROLONTIS is being investigated for the treatment of chemotherapy-induced neutropenia. POZIOTINIB is an oral pan-HER inhibitor that irreversibly blocks signaling through the Epidermal Growth Factor Receptor (EGFR, HER) Family of tyrosine-kinase receptors, including HER1 (erbB1; EGFR), HER2 (erbB2), HER4 (erbB4), and HER receptor mutations.
展开

微牛提供Spectrum Pharmaceuticals, Inc.(NASDAQ-SPPI)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的SPPI股票新闻,以帮助您做出投资决策。